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Highlights 
► Hepatitis E virus (HEV) was searched in raw and treated wastewater in Switzerland. 
► HEV was found frequently in influent wastewater, but was undetectable in effluent. 
► HEV occurrences in wastewater are more frequent in summer (seasonal pattern). 
► HEV found in wastewater does not seem to be produced by swine. 
► HEV frequencies and concentration are lower than those of adenovirus and norovirus. 
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Abstract 21 
Hepatitis E virus (HEV) is responsible for many enterically transmitted viral hepatitides around the 22 
world. It is currently one of the waterborne diseases of global concern. In industrialized countries, 23 
HEV appears to be more common than previously thought, even if it is rarely virulent. In 24 
Switzerland, seroprevalence studies revealed that HEV is endemic, but no information was 25 
available on its environmental spread. The aim of this study was to investigate –using qPCR– the 26 
occurrence and concentration of HEV and three other viruses (norovirus genogroup II, human 27 
adenovirus-40 and porcine adenovirus) in influents and effluents of 31 wastewater treatment 28 
plants (WWTPs) in Switzerland. Low concentrations of HEV were detected in 40 out of 124 WWTP 29 
influent samples, showing that HEV is commonly present in this region. The frequency of HEV 30 
occurrence was higher in summer than in winter. No HEV was detected in WWTP effluent 31 
samples, which indicates a low risk of environmental contamination. HEV occurrence and 32 
concentrations were lower than those of norovirus and adenovirus. The autochthonous HEV 33 
genotype 3 was found in all positive samples, but a strain of the non-endemic and highly 34 
pathogenic HEV genotype I was isolated in one sample, highlighting the possibility of 35 
environmental circulation of this genotype. A porcine fecal marker (porcine adenovirus) was not 36 
detected in HEV positive samples, indicating that swine are not the direct source of HEV present 37 
in wastewater. Further investigations will be necessary to determine the reservoirs and the routes 38 
of dissemination of HEV. 39 
 40 
Keywords 41 
Hepatitis E, HEV, norovirus, adenovirus, wastewater, qPCR 42 
 43 
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1. Introduction 44 
Many waterborne diseases, like gastroenteritis or hepatitis, are caused by viruses and are a major 45 
threat to public health (Bosch et al., 2008). Human viruses such as adenovirus type 40 (HAdV-40) 46 
and noroviruses (NoV) genogroup I (GGI) and genogroup II (GGII) are commonly found in 47 
wastewater due to fecal excretion. Wastewater is treated physically, chemically, and biologically 48 
in wastewater treatment plants (WWTPs) in order to eliminate or reduce contaminants before the 49 
release of environmentally safe water. Fecal pollution of environmental water is a major health 50 
concern since environmental waters are used for drinking water supply and food production. 51 
Moreover, released viruses might reach diverse food items such as vegetables, fruits and raw 52 
shellfish (Bosch et al., 2008). Some viruses, like HAdV-40 and NoV, are good fecal indicators for 53 
evaluating the microbiological quality of environmental water, since they are excreted in high 54 
concentrations and are persistent in environmental water (Roslev and Bukh, 2011). Furthermore, 55 
viruses can be used to track the sources of fecal contamination (Roslev and Bukh, 2011). It is 56 
possible to distinguish between human and animal sources of pollution, since many human and 57 
animal viruses have a very narrow host spectrum. For example, HAdV-40, bovine adenovirus 58 
(BAdV) and porcine adenovirus (PAdV) are good indicators for determining the source of fecal 59 
contamination (Hundesa et al., 2006). 60 
 61 
Hepatitis E is a waterborne disease responsible for over 50% of acute viral hepatitis cases in 62 
endemic countries (Dalton et al., 2008; Meng, 2010). The disease is caused by the hepatitis E virus 63 
(HEV), which is a non-enveloped positive-strand RNA virus (Dalton et al., 2008; Meng, 2010). HEV 64 
infection in humans can be caused by 4 genotypes (GI, GII, GIII and GIV) resulting in a single 65 
serotype (Dalton et al., 2008; Meng, 2010). Epidemics occur in countries with poor sanitation 66 
systems (Asia, Africa, Middle East and Mexico) and are due to GI and GII (Dalton et al., 2008; 67 
Meng, 2010). GI is a hyper-virulent genotype, responsible for most of the large outbreaks(Dalton 68 
et al., 2008; Meng, 2010; Bose et al., 2011). Furthermore, GI strongly affects pregnant woman by 69 
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causing fulminant hepatic failure, which can lead to the death of both mother and child (Bose et 70 
al., 2011). For a long time, HEV was considered non-endemic in industrialized countries as only 71 
sporadic travel-associated cases were reported (Purcell and Emerson, 2008). However, the 72 
increasing number of autochthonous cases and the high seroprevalence reported in certain 73 
countries indicated that HEV is actually endemic to these countries (Purcell and Emerson, 2008). 74 
These autochthonous cases are due to GIII in most industrialized countries and to GIV in Eastern 75 
Asia (Purcell and Emerson, 2008; Lewis et al., 2010; Colson et al., 2012). Whereas GI and GII are 76 
restricted to humans, GIII and GIV have a wider host range within mammals and their main 77 
reservoir is suspected to be pigs and wild boar (Lewis et al., 2010; Meng, 2010; Rose et al., 2011; 78 
Wacheck et al., 2012). Hepatitis E has received ever more attention in recent years and is now 79 
considered an emerging problem. Its success in spreading may illustrate weaknesses in water 80 
management systems or food processes related to pork. 81 
 82 
Studying the occurrence of enteric pathogens in influents at WWTP provides an efficient overview 83 
of the presence of these pathogens in the population. HEV has been detected in WWTPs in France 84 
(Clemente-Casares et al., 2003), Italy (La Rosa et al., 2010) and Spain (Clemente-Casares et al., 85 
2009; Rodriguez-Manzano et al., 2010). The presence of the non-endemic GI in wastewater was 86 
recently reported in Spain and Italy (Clemente-Casares et al., 2009; La Rosa et al., 2010). HEV 87 
seroprevalence rates in populations from industrialized countries are usually relatively low (i.e. 88 
ranging from 1% to 5%) in comparison to those in developing countries, where rates from 15% to 89 
60% have been reported (Dalton et al., 2008). Seroprevalence rates exceeded 20% in some 90 
regions within the USA (Thomas et al., 1997; Meng et al., 2002) and Japan (Li et al., 2000), 91 
showing that seroprevalence rates can reach locally unexpected higher values. However, 92 
comparison of seroprevalence between regions is problematic due to a lack of standardised 93 
serological tests (Bendall et al., 2010). In Switzerland, two blood donor studies reported HEV 94 
seroprevalence of 3.2% and 4.9% respectively (Lavanchy et al., 1994; Kaufmann et al., 2011). 95 
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Furthermore, 26 cases of asymptomatic HEV seroconversion were recorded in a cohort of 667 96 
workers including 332 WWTP workers in 5 years (Tschopp et al., 2009). Since these infections 97 
were asymptomatic, it was hypothesized that the workers were infected by the low pathogenic 98 
HEV GIII. However, neither the genotype involved in these seroconversions, nor the source of 99 
infection, could be determined accurately.  100 
 101 
The present study investigated the occurrence and the concentration of HEV in the influents and 102 
effluents of 31 WWTPs located in the same area as the above mentioned cohort study (Jeggli et 103 
al., 2004; Tschopp et al., 2009). The objectives were to assess the environmental circulation of 104 
HEV in Switzerland and to determine whether HEV GI is present in wastewater. As points of 105 
comparison, the occurrence and concentration of two human viruses, HAdV-40 and NoV-GGII, 106 
were assessed. PAdV, a porcine fecal marker, was searched in order to evaluate whether any 107 
detected HEV might be of porcine origin.  108 
 109 
2. Materials and methods 110 
2.1. Sampling site selection 111 
Thirty-one municipal WWTPs were selected within the Canton of Zurich in Switzerland (about 1.39 112 
million inhabitants; 1,729 km
2
). All WWTPs comprise a cleaning and an activated sludge step 113 
(“Zurich WWTP website,” 2013). The selection was made using the following criteria. First, 114 
WWTPs where a seroconversion in workers had been ascertained in the recent cohort study on 115 
hepatitis E incidence (Tschopp et al., 2009) were included. Second, the WWTP servicing Zurich’s 116 
international airport was included because international travelling increases the probability of the 117 
occurrence of genotypes GI and GII. Third, WWTPs where occupational hygiene measurements 118 
had been taken in a previous study (Oppliger et al., 2005; Daneshzadeh Tabrizi et al., 2010) were 119 
included. Finally, further WWTPs were selected to represent a well-balanced sample of the whole 120 
canton. The final sample included 6 very large (> 50,000 inhabitants and inhabitant-equivalents), 121 
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12 large (10,000–50,000 inhabitants and inhabitant-equivalents) and 13 small WWTPS (2,000–122 
10,000 inhabitants and inhabitant-equivalents). Very small WWTPs (< 2,000 inhabitants and 123 
inhabitant-equivalents) were not included, but there was always a larger WWTP in the same area. 124 
A total of 247 pig farms housing about 43,000 pigs were recorded in the Canton of Zurich 125 
(“Federal Office of Statistics,” 2013). These WWTPs treat only household sewage and farmers are 126 
not allowed to use these sewer systems to eliminate animal sewage. The processes used to 127 
eliminate animal sewage are diverse (production of biogas, spreading on fields as a fertilizer...). 128 
 129 
2.2. Sample collection 130 
Both in 2010 and 2011, we collected one summer sample (defined as June to August) and one 131 
winter sample (defined as November to January) from each WWTP. Each seasonal collection 132 
campaign lasted four weeks. At each WWTP, 24-hour composite samples of both influent and 133 
effluent were collected in parallel using sterile plastic bottles. The 248 samples collected were 134 
stored at 4°C for up to 12 h, then frozen at -20°C and stored at -80°C for no more than 40 days. 135 
Before concentration, samples were allowed to slowly liquefy at 4°C.  136 
 137 
2.3. Generation of standard curve, calculation of virus concentration, and 138 
controls 139 
Standards were prepared from plasmids (pGEM-T cloning vector, Promega, Switzerland) 140 
containing corresponding PCR products. DNA was quantified by spectrophotometry using a 141 
Nanodrop ND-1000 spectrophotometer (Thermo Fisher Scientific, Switzerland), and 10-fold serial 142 
dilutions, ranging from 10
6
 to 1 genome equivalent (GE) copies/µL, were prepared for each 143 
plasmid. The sets of serial dilutions were used to confirm the specificity and the efficiency of the 144 
assays, to generate the standard curves, and to establish the limits of quantification (LOQ) and the 145 
limits of detection (LOD). Based on these standard curves and dilution calculations, all qPCR 146 
assays were converted from GE copies/reaction to GE copies/L. 147 
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Three duplex qPCR assays were developed to allow simultaneous detection of viruses: NoV-148 
GGII/RYMV and HEV/RYMV for RNA viruses, and HAdV-40/PAdV for DNA viruses. The reaction 149 
efficiencies were measured on serial 10-fold dilution mixtures of 2 virus amplicons cloned in 150 
pGEM-T as described for the monoplex assays. Cross-reactivity between the assays in duplex was 151 
evaluated by comparing the amplification of the target in single-plasmid solution and in multiple 152 
plasmid solution. 153 
 154 
2.4. Virus control 155 
To ensure that every sample had been treated appropriately to allow detection of target viruses, 156 
we used the Rice Yellow Mottle Virus (RYMV) isolate CI116 as an internal positive control. RYMV is 157 
a plant pathogen present mainly in Africa and Asia, but absent from Europe (Kouassi et al., 2005). 158 
This virus is very resistant in the environment and is structurally similar to HEV (no envelope, one 159 
single-strand RNA with positive polarity). Preliminary experiments showed that seeded RYMV is 160 
efficiently recovered from wastewater (data not shown). Virus stock solutions were kindly 161 
provided by Jean-Paul Brizard (IRD Montpellier) and were quantified by qPCR. An amount of 2 × 162 
10
6
 GE copies of RYMV was used to spike each sample. The quality of each sample was assessed 163 
by the efficient amplification of RYMV. The sample validation threshold was 4 × 10
5
 GE copies of 164 
RYMV. Samples with an amplification of spiked RYMV under the threshold were reanalyzed or not 165 
considered. 166 
 167 
2.5. Virus concentration from water samples 168 
Viruses were concentrated from water samples either by a membrane filtration procedure 169 
adapted to HEV (method used in first year) or using a direct polyethylene glycol precipitation 170 
(method used in second year). The membrane filtration procedure was based on the Viradel 171 
method (Eaton and Franson, 2005). Briefly, 500 mL of cold water samples under agitation were 172 
supplemented with 50 mM MgCl2 and adjusted to a pH of 3.5 with HCl. Water was filtered 173 
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through a glass fiber pre-filter (AP20, Millipore, Switzerland) and an electronegative nitrocellulose 174 
membrane (HA, Millipore, Switzerland) at 50 mL/min. Filters were washed with cold 0.05 M 175 
glycine, 1.5% beef extract, pH=9.5. Filter surfaces were scratched and a bath sonication treatment 176 
was applied for 5 min. Eluates were neutralized with diluted HCl and centrifuged at 2500g for 5 177 
min at 4°C. The supernatant was spiked with RYMV and precipitated with PEG as described below. 178 
The pellet was resuspended in 460 µL of PBS. Nucleic acids were directly extracted from 140 µL of 179 
this suspension. 180 
 181 
For the direct precipitation method, influent and effluent water samples were concentrated using 182 
polyethylene glycol as described previously (Lewis and Metcalf, 1988) with the following 183 
modifications. Briefly, 90 mL water samples were spiked with RYMV and clarified by 184 
centrifugation in a swing-bucket rotor at 2500g for 5 min at 4°C. The liquid was carefully 185 
recovered without disturbing the pellet and 30 mL of a stock solution of 32% PEG8000 and 1.2 M 186 
NaCl were added to the recovered liquid. PEG precipitation was achieved by a short, vigorous 187 
shaking followed by incubation for 16 h in ice. The solutions were then centrifuged at 10000g for 188 
30 min at 4°C in a fixed-angle rotor. The pellet was drained from most of the supernatant and 189 
directly treated with 560 µL of lysis buffer (AVL buffer, Qiagen, Switzerland) to start nucleic acid 190 
extraction. 191 
 192 
2.6. Evaluation of the efficiency of the virus concentration methods. 193 
The recovery efficiency of the filtration method was evaluated by spiking raw wastewater samples 194 
(n=3) with HEV (5 × 10
5
 GE copies). Spiked samples were concentrated by filtration and 195 
quantification was performed by qPCR after reverse transcription (RT). Using this approach, the 196 
LOQ was established at 5.02 × 10
4
 GE copies/L. The recovery efficiency of the PEG precipitation 197 
method was determined by spiking water samples (n=5) with known quantities of HEV (5 × 10
5
 GE 198 
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copies) and RYMV (2 × 10
6
 GE copies). Spiked samples were precipitated with PEG and nucleic 199 
acids were extracted from the pellets. HEV and RYMV were quantified by qPCR after RT. 200 
 201 
2.7. Extraction of viral nucleic acid 202 
RNA and DNA were extracted together from concentrated samples with the QIAamp Viral RNA 203 
mini kit (Qiagen, Switzerland) using the manufacturer's protocol. After elution, an additive 204 
ethanol precipitation cleaning step was carried out on the samples, using Glycoblue (Ambion, 205 
Switzerland) as a co-precipitant. The nucleic acids were finally suspended again in 60 μl of AVE 206 
buffer and stored at -20°C until use. 207 
 208 
2.8. Reverse transcription 209 
Reverse transcription was carried out using the Superscript III first-strand synthesis system for RT-210 
PCR (Life Technologies, Switzerland) and a mixture of reverse primers priming towards the 211 
particular RNA viruses to be detected (Table S1). The 20 µL reaction mix included 10 µL of RNA 212 
solution and was prepared as per the manufacturer’s protocol, using RNAsin (Promega, 213 
Switzerland) as the RNase inhibitor. The reaction was incubated for 60 min at 50°C and heat-214 
inactivated at 70°C for 15 min. The cDNAs were finally diluted to 100 µL with TE 0.1X. No 215 
difference of RT efficiency was detected when using a single reverse primer or a mixture of 216 
reverse primers in the reaction mix. 217 
 218 
2.9. qPCR assay 219 
Each reaction was performed on 5 µL of nucleic acid solution with the qPCR core kit (No ROX, with 220 
dUTP, Eurogentec, Switzerland) as per the manufacturer’s protocol. All reactions were performed 221 
in a RotorGene-3000 (Corbett Research/Qiagen, Switzerland) using the following profile: digestion 222 
with uracil-N-glycosylase at 50°C for 2 min; initial denaturation at 95°C for 10 min; 45 cycles of 15 223 
s denaturation at 95°C; and 30 s annealing and extension at 60°C. Each sample was analyzed in 224 
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triplicate and the corresponding mean was reported. No template controls were included in each 225 
run. We followed good laboratory practices strictly and took all necessary standard precautions to 226 
prevent PCR contamination (separate working areas and specific material for extraction, 227 
preparation and amplification of samples). Quantitative data were obtained with RotorGene 228 
software version 6.1.93 and were subsequently analyzed using custom-designed Excel 229 
spreadsheets using the standard curve equation as a reference for the quantification. A 230 
normalized fluorescence signal (Cq value) was considered to be positive when it was above the 231 
threshold for Cq determination defined for the standard curve. 232 
 233 
2.10. Nested PCR for detection of HEV GI or HEV GIII 234 
Nested PCR was performed with a set of primers allowing specific amplification of HEV GI (La Rosa 235 
et al., 2010). The reverse internal primer was modified to take into account the variability of HEV 236 
GI in this region (Table S1). The first reaction was carried out on 5 µL of cDNA in a total volume of 237 
50 μl containing Pfu PCR buffer 1× (Promega, Switzerland), 200 μM of each deoxynucleotide 238 
(dATP, dCTP, dGTP, dTTP), 0.4 µM of each external primer, and a combination of polymerases–1 U 239 
of Taq polymerase (Promega, Switzerland) and 0.2 U of Pfu polymerase (Promega, Switzerland) to 240 
achieve efficient amplification at low error rate. PCR amplification included: an initial 241 
denaturation step at 94°C for 1 min; followed by 35 cycles of denaturation at 94°C for 45 s; primer 242 
annealing at 50° C for 45 s; and an extension step at 72°C for 1 min; and then a final extension 243 
step at 72°C for 5 min. A second round of amplification was performed similarly to the first PCR, 244 
using the internal primers and 0.5 µL of the first PCR product. PCR products were identified by 245 
electrophoresis in 1.5% agarose gels and stained by ethidium bromide. Positive PCR samples were 246 
confirmed by direct sequencing. Strict precautions were taken to avoid cross-contamination, as 247 
described above. HEV GIII was detected with the same protocol using 3 GIII-specific primers to 248 
allow efficient detection (Table S1). 249 
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3. Results 250 
3.1. Validation of the qPCR assays 251 
With the exception of the qPCR assay to amplify the internal positive control RYMV, the specificity 252 
and efficiency of the qPCR assays have been previously described (Table S1 and references 253 
therein). We evaluated the ability of the different qPCR assays to efficiently amplify their targets 254 
under our conditions. Reaction efficiencies and specificity were confirmed for all qPCR assays 255 
(Supplemental Table S2). 256 
Three duplex assays were developed for the detection of viruses: NoV-GGII/RYMV, HEV/RYMV, 257 
and HAdV-40/PAdV. Duplex qPCRs showed equivalent reaction efficiencies to the corresponding 258 
monoplex qPCR (Supplemental Table S2). Furthermore, no cross-reactivity was observed for any 259 
duplex assay combination. 260 
 261 
3.2. Evaluation of the membrane filtration and PEG precipitation methods for 262 
virus recovery from water samples 263 
The first method, based on a membrane filtration of HEV-spiked samples, showed a mean 264 
recovery efficiency of 30% (n=3) and ranged from 12% to 45%. The second method was evaluated 265 
based on a direct PEG precipitation of clarified wastewater samples. The recovery efficiency for 266 
HEV had a mean of 39% (n= 5) and ranged from 25% to 53%. For RYMV, the recovery efficiency 267 
ranged from 58% to 71% with a mean recovery efficiency of 66% (n=5). 268 
As the PEG precipitation method could lead to the concentration of enzymatic inhibitors, the 269 
effect of such compounds on PCR and RT efficiency was evaluated. Compared to the spiked 270 
distilled water sample, PCR efficiency was reduced to 71% and 81% in influent and effluent water 271 
samples respectively (Table S3). RT efficiency was reduced to 79% for influent water samples 272 
(Table S4). 273 
 274 
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3.3. Occurrence and concentrations of HEV in influent wastewater 275 
HEV was detected in 17 samples from summer 2010, 8 samples from winter 2010-2011, 14 276 
samples from summer 2011 and 1 sample from winter 2011-2012 (Fig. 1). HEV occurrence in 277 
summer was significantly higher than in winter (Marascuillo procedure, p < 0.05, Fig. 1). The 278 
presence of the virus in wastewater was variable since not one WWTP was positive in all 4 279 
successive samplings and the majority of WWTPs had a single occurrence. Only 7 of the WWTPs 280 
did not test positively for HEV at all over the two consecutive years. There is no difference of HEV 281 
occurrence between the size categories of the WWTP with 44.4% (8/18) of large WWTP (> 10’000 282 
inhabitants) positive compared to 46.1% (6/13) of small WWTP (< 10’000 inhabitants), (Pearson 283 
Chi-square = 0.009, df = 1, p = 0.9). The overall HEV concentration in the study was low since 284 
values under the LOQ were reported for every sample but one. Therefore, the concentration of 285 
HEV in wastewater was only determined in this single sample from summer 2011. A concentration 286 
of 7.81 × 10
4
 GE copies/L was found for this sample (Table 1). 287 
 288 
3.4. Occurrence and concentrations of human and porcine fecal virus in influent 289 
wastewater 290 
NoV-GGII was detected in 30 summer samples and 30 winter samples (Table 1). Quantification 291 
was possible for 21 summer samples and their concentrations ranged from 7.40 × 10
4
 to 3.73 × 292 
10
6
 GE copies/L. In 22 winter samples, concentrations ranged from 1.22 × 10
4
 to 9.99 × 10
5
 GE 293 
copies/L. HAdV-40 was detected in 30 summer samples and 31 winter samples (Table 1). In 26 294 
summer samples, HAdV-40 concentrations ranged from 1.88 × 10
4
 to 6.67 × 10
6
 GE copies/L. 295 
Twenty-four winter samples were quantifiable and showed concentrations ranging from 1.12 × 296 
10
4
 to 1.43 × 10
6
 GE copies/L. The PAdV was not detected in summer, although 2 samples showed 297 
traces of the virus in winter.  298 
 299 
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3.5. Detection of HEV genotype I in influent wastewater 300 
To determine whether HEV GI is present in wastewater, a GI-specific semi-nested PCR was 301 
performed on the HEV positive samples identified by qPCR. Only one sample produced a positive 302 
221-bp PCR band, which was isolated and sequenced. This sample corresponded to a very large 303 
WWTP (ARA27, Table 1). The new sequence was submitted to the Basic Local Alignment Search 304 
Tool (BLAST) web server (US National Centre for Biotechnology Information) to search for near 305 
identical sequences. The result revealed that the most closely related sequence (98% identity) 306 
was a HEV genotype I strain isolated from Nepal (Genbank HM641296, Fig. S1). Alignment with 307 
the corresponding 221-bp region of selected HEV strains of all genotypes showed that this new 308 
sequence belongs to GI group of HEV strains (phylogenetic tree, Fig. 2). 309 
 310 
3.6. Occurrence of viruses in WWTP effluents wastewater 311 
We searched for HEV in effluent samples from WWTPs which had HEV positive influent samples 312 
(14 summer samples and 1 winter sample). As a control, 10 randomly selected effluent samples 313 
for which influent samples were negative for HEV were also included in the analysis. None of 314 
these samples was positive for HEV. The NoV-GGII concentrations were evaluated in effluent 315 
samples from WWTPs for which quantifiable virus loads were found in influent samples (21 316 
summer samples and 22 winter samples). For most samples, NoV-GGII concentrations from 317 
influent to effluent were reduced under the LOQ (1.86 × 10
4
 GE copies/L) (Table 2). Only 2 318 
summer and 3 winter effluent samples were above the LOQ (Table 2). However, traces of NoV-319 
GGII were still detected in 7 summer and 11 winter effluent samples. The HAdV-40 concentrations 320 
were evaluated in effluent samples from WWTPs for which quantifiable HAdV-40 loads were 321 
found in influent samples (26 summer samples and 24 winter samples). All but 3 effluent samples 322 
were positive for HAdV 40 (Table 2). Among these, 13 summer and 5 winter samples displayed 323 
quantifiable HAdV-40 levels. (Fig. 3). 324 
 325 
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
15 
 
4. Discussion 326 
These results clearly demonstrate the presence of HEV in the Canton of Zurich, as previously 327 
hypothesized by studies on HEV seroprevalence (Jeggli et al., 2004; Tschopp et al., 2009). We 328 
showed a 32% (40/124) HEV occurrence in WWTP influent samples, with a significantly higher 329 
occurrence in summer than in winter. This occurrence is similar to that observed in Spain 330 
(Rodriguez-Manzano et al., 2010) and higher than that reported from WWTPs in Italy (La Rosa et 331 
al., 2010). However, HEV quantification was only possible for one sample since virus 332 
concentrations were too low in all the others. The calculated concentration was in the same range 333 
as those found in Spain: 1 × 10
4
 GE copies/L to 1 × 10
5
 GE copies/L (Rodriguez-Manzano et al., 334 
2010). 335 
 336 
Untreated wastewater contains many infectious agents and the safety of WWTP workers has 337 
been of interest for many years. The study by Tschopp et al. (2009) showed that there was no 338 
difference in the rates of HEV seroconversion between workers exposed to wastewater and 339 
unexposed workers. Our results confirm that concentrations of HEV circulating in wastewater are 340 
quite low compared to concentrations of HAdV-40 and NoV-GII – viruses which were found in 341 
nearly all samples. In consequence, under the exposure conditions found in this study WWTP 342 
workers’ risk of exposure to HEV GIII is likely to be limited and comparable to the risk in the 343 
general population. This conclusion is in line with the results of the cohort study carried out in the 344 
same region (Jeggli et al., 2004; Tschopp et al., 2009). However, the risk of HEV infection for 345 
individuals is difficult to assess since the infectious dose and the routes of transmission are not 346 
clearly defined. 347 
 348 
The concentration of infectious HEV particles in raw wastewater is probably lower than the 349 
concentration of particles detected by qPCR since particles may be damaged by wastewater plant 350 
treatments. It is difficult to assess the viability of HEV particles since the virus is refractory to in 351 
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vitro culture methods. However, infectious viral particles can survive wastewater treatment as 352 
demonstrated by HAdV and other viruses (Calgua et al., 2011; Simmons and Xagoraraki, 2011). In 353 
addition, some particles might not be recovered or might be damaged by the concentration 354 
process. New methods with high recovery efficiency, low LOQ and preservation of the particles 355 
still need to be developed (Connell et al., 2012). During our study’s first year we used the 356 
membrane filtration method to concentrate viruses from wastewater samples. However, some 357 
influent wastewater samples were significantly turbid or contained particles that clogged the 358 
double filter, requiring the continuous intervention of the experimenter. We tested the direct PEG 359 
precipitation method to avoid clogging problems and to allow time-efficient processing of the 360 
samples. This method, described previously (Lewis and Metcalf, 1988), has been used to 361 
efficiently recover viruses from water samples (Aw and Gin, 2010; Tong et al., 2011). Moreover, 362 
many virus species can be concentrated at the same using this method. Compared to the 363 
membrane filtration method, the direct PEG precipitation method is more adapted to raw 364 
wastewater samples, which have high turbidity and variable composition. Our comparison of the 365 
2 methods showed that both methods have similar HEV recovery efficiencies. Since the PEG 366 
precipitation method was highly more practical than the membrane filtration method, with no 367 
interference on the results, we used it during our second year of study. 368 
 369 
The WWTPs included in our study all used activated sludge treatment, but they varied in size, 370 
structural organization and location. Our objective was not to determine the virus removal 371 
capabilities of WWTPs, but rather to evaluate the possibility of virus release from those WWTPs to 372 
environmental water. HEV was not detected in any effluent samples, which is in agreement with 373 
the low concentrations detected in influent samples. However, we cannot completely rule out the 374 
possibility of HEV release into environmental water since the detection method cannot detect 375 
concentrations lower than 6.50 × 10
4
 GE copies/L. Although wastewater treatment processes 376 
efficiently reduced the concentrations of NoV-GGII in most samples, the presence of NoV-GGII 377 
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was still detected in 9 summer and 14 winter effluent samples. Furthermore, 2 summer and 3 378 
winter effluent samples showed a NoV-GGII concentration higher than the LOQ (1.86 × 10
4
 GE 379 
copies/L). Other studies have reported the frequent release of NoV-GGII in WWTP effluent 380 
(Katayama et al., 2008; Hewitt et al., 2011; Simmons and Xagoraraki, 2011). Although 381 
concentrations of HAdV-40 were reduced in many of them, the virus persisted in effluent samples. 382 
This result is explained by the highly resistant properties of this virus (Thurston-Enriquez et al., 383 
2003). 384 
 385 
In this study, we observed that the occurrence of HEV in wastewater is significantly higher in 386 
summer than in winter. This seasonal difference could depend on many factors, such as particle 387 
stability, environmental conditions or outbreaks. The possible influence of incoming water flow is 388 
unlikely, since there is no remarkable difference in flow between the seasons (Head of Zurich 389 
WWTPs, pers. comm.). It is noteworthy that medical studies of HEV infection have never revealed 390 
a seasonal pattern. Since HEV GIII usually causes an asymptomatic infection, it is possible that 391 
most cases of HEV remain not diagnosed. We also found that NoV-GGII and HAdV-40 were 392 
present in almost all influent water samples at high, stable concentrations (Table 1), as little 393 
variation was observed between the 2 seasons. HAdV-40 is known to be widespread in the 394 
European population, where it can cause outbreaks of gastroenteritis, mostly in children during 395 
winter. After infection, HAdV-40 excretion by the host can last from months to years (Jiang, 2006) 396 
and the consequent lack of a seasonal pattern for this virus in wastewater has been confirmed by 397 
several studies (Jiang, 2006; Katayama et al., 2008). NoV-GGII is also common in the European 398 
population and is frequently responsible for winter gastroenteritis outbreaks (Glass et al., 2009). 399 
Our study in Switzerland clearly shows that NoV-GGII is present in wastewater in both winter and 400 
summer, without any noteworthy variation. Other studies have found that NoV-GGII is present in 401 
wastewater year-round, with higher concentrations in winter and lower concentrations in 402 
summer (Katayama et al., 2008; Nordgren et al., 2009). Since NoV-GII outbreaks mainly occur in 403 
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the cold season and the typical shedding time is up to 8 weeks, further investigations are required 404 
to understand the dynamics of NoV-GGII persistence in population.  405 
 406 
In industrialized countries, most cases of HEV infection are due to the autochthonous zoonotic 407 
GIII and GIV variants whose reservoir might be swine (Lewis et al., 2010; Meng, 2010; Rose et al., 408 
2011; Wacheck et al., 2012). In theory, swine manure is kept completely separate from 409 
wastewater, but hypothetical dysfunctions or accidental contaminations cannot be absolutely 410 
eliminated. Absence of the porcine fecal marker (i.e. PAdV) in our HEV-positive wastewater 411 
samples indicates that HEV was unlikely excreted by swine. 412 
 413 
Medical cases of HEV GI are not frequent in Europe since this genotype is non-endemic to the 414 
region. However, the present study did detect GI in one sample, showing that its occurrence in 415 
wastewater, although very rare, is still possible. Interestingly, studies in non-endemic Italy and 416 
Spain, also showed the presence of GI in wastewater (Clemente-Casares et al., 2009; La Rosa et 417 
al., 2010). Overall, these results show that GI can be detected in wastewater produced in 418 
industrialized countries. It is assumed that GI released in wastewater is due to people who have 419 
recently travelled to a GI-endemic country. This assumption is confirmed by the alignment of our 420 
detected GI sequence–with a HEV strain originating from Nepal (Fig. 2 and S1). However, it is not 421 
known if HEV GI present in wastewater can spread into the environment and infect a new host. 422 
Follow-up studies are necessary, especially in the light of unknown reservoirs for HEV in 423 
industrialized countries. 424 
 425 
 426 
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5. Conclusions 427 
• HEV is present frequently but at low concentrations in raw wastewater in the Canton of 428 
Zurich in Switzerland, indicating that HEV is common in the population of the area 429 
studied. 430 
• There was no evidence of HEV release from WWTPs into environmental water. 431 
• HEV frequency depends on the season, with higher frequencies of HEV detection in 432 
summer. The seasonal character of HEV occurrence has not been previously described 433 
and requires further investigation to understand its causes. 434 
 435 
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Figure legends 578 
Fig. 1 – Results of HEV detection in influent samples. Selected WWTPs were randomly labeled 579 
with an identifier ranging from ARA01 to ARA31. A total of 31 influent samples were analyzed for 580 
each season. Different letters indicate significant differences (p < 0.05) between seasonal 581 
proportions according to multiple comparisons of proportions (Marascuillo procedure).  582 
 583 
Fig. 2 – Phylogenetic tree of HEV strains. Analysis was based on a 221-bp region of HEV genome. 584 
The new sequence GI from a positive WWTP influent (named "WWTP influent sample") and a 585 
subset of HEV sequences of all genotypes were included in this analysis. Sequences were aligned 586 
using MAFFT (Katoh and Standley, 2013) and the corresponding unrooted phylogenetic tree was 587 
generated with Jalview (Waterhouse et al., 2009). Known sequences are labeled with Genbank 588 
accession, country of origin, genotype, and start and final positions used for the alignment. The 589 
location of the new sequence GI in the phylogenetic tree is indicated with an arrow.  590 
 591 
Fig. 3 – Concentration of HAdV-40 in influent and effluent water samples. Results are expressed as 592 
log10 virus GE per liter. Box plots are generated with influent and effluent concentrations from 593 
WWTPs where both influent and effluent samples were quantifiable (WWTPs in summer n = 13, 594 
WWTPs in winter n = 5). 595 
 596 
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Table 5 – Detection and concentration of viruses in influent samples. 
 
 
 HEV NoV-GGII HAdV-40 PAdV 
Sampling 
sites 
summer winter summer winter summer winter summer winter 
ARA01   1.96 × 105 + 2.67 × 104 5.62 × 105   
ARA02 +  3.79 × 105 8.78 × 104 7.50 × 105 1.17 × 106   
ARA03 +  3.86 × 105 3.36 × 105 5.18 × 105 1.43 × 106   
ARA04   4.10 × 105 9.99 × 105 1.46 × 105 5.40 × 105   
ARA05 +  1.73 × 105 1.16 × 105 1.88 × 104 3.83 × 104   
ARA06 +  6.62 × 105 9.99 × 104 + +   
ARA07 +  + 5.13 × 104 1.78 × 106 +   
ARA08   + 4.09 × 105 1.00 × 105 4.79 × 105   
ARA09   1.35 × 105 1.97 × 105 3.06 × 104 +   
ARA10 +  + + 1.67 × 105 1.96 × 104  + 
ARA11 +  6.50 × 105 1.28 × 105 1.39 × 105 4.78 × 105   
ARA12  + + + 4.21 × 104 2.19 × 104   
ARA13 +  7.40 × 104 5.83 × 104 + 3.66 × 105   
ARA14 +  5.60 × 105 2.82 × 105 5.33 × 105 4.07 × 105   
ARA15    1.24 × 104 3.63 × 105 2.52 × 105   
ARA16 +  1.77 × 105 7.83 × 104 + 7.65 × 105   
ARA17 +  1.53 × 105 + 4.45 × 105 1.96 × 104   
ARA18   + 2.63 × 104 7.55 × 104 1.95 × 105   
ARA19   8.75 × 104  2.06 × 104 1.56 × 104   
ARA20 +  + + 1.45 × 105 +   
ARA21   1.83 × 105 2.91 × 104 6.67 × 106 +   
ARA22   3.06 × 105 3.63 × 104 8.56 × 105 1.48 × 105   
ARA23   3.73 × 106 +  +   
ARA24   1.16 × 105 5.88 × 104 3.07 × 104 1.15 × 105   
ARA25   + 1.22 × 104 + 6.15 × 105  + 
ARA26 +  3.26 × 105 1.23 × 105 1.78 × 106 1.23 × 105   
ARA27 7.81 × 104  5.20 × 105 2.39 × 104 8.04 × 105 4.27 × 104   
ARA28   8.46 × 105 + 7.35 × 105 2.77 × 104   
ARA29   + + 5.07 × 104 3.11 × 104   
ARA30   1.47 × 105 1.90 × 104 2.11 × 105 1.12 × 104   
ARA31     + 7.42 × 104 1.24 × 106 +     
mean – – 4.86 × 105 1.48 × 105 6.80 × 105 3.28 × 105 – – 
LOQ  6.50 × 104 1.86 × 104 9.27 × 103 5.67 × 103 
+: positive qPCR signal under the limit of quantification (LOQ). Blanc: no detection. Values are expressed in GE.L-1 
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Table 6: Efficiency of the WWTP processes on virus concentration reduction. 
    NoV-GGII HAdV-40 
        summer winter summer winter 
Number of WWTPs with a quantifiable virus charge (influent)
1
 21 22 26 24 
        
No detection 12 8 0 3 
Detection below LOQ
2
 7 11 13 16 
Detection results in the corresponding 
effluent samples 
Detection above LOQ 2 3 13 5 
1
Only WWTPs with an influent concentration of virus higher than LOQ are considered. 
 
 
 
 
2
LOQ = limit of quantification      
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2011
Winter
2011 - 2012
Summer 
2010
Winter
2010 - 2011
14 / 31 1 / 3117 / 31 8 / 31
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HM055578_Hungary_GIII_(4375-4529)
FJ705359_Germany_GIII_(4424-4578)
AB630971_Japan_GIII_(4424-4512)
HQ389543_UK_GIII_(4440-4594)
AF060669_USA_GIII_(4449-4537)
FJ426404_South_Korea_(4417-4507)
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Table S1 – List of primers used in this study 
 
Virus 
Primer or 
probe name 
Other name Sequence (5'-3') Orientation Position
1
 
Amplicon 
size 
Reference 
NoV-GGII Noro-fwd JJV2F CAAGAGTCAATGTTTAGGTGGATGAG + 5003–5028 98 bp Jothikumar et al 2005 
(RNA virus) Noro-rev COG2Ra TCGACGCCATCTTCATTCACA - 5100–5080 
  
  Noro-prob RING2-TPa (FAM-)TGGGAGGGCGATCGCAATCT(-TAMRA) + 5048–5067 
  
        
HEV HEV-fwd JVHEVF GGTGGTTTCTGGGGTGAC + 5285–5301 70 bp Jothikumar et al 2006 
(RNA virus) HEV-rev JVHEVR AGGGGTTGGTTGGATGAA - 5354–5337 
  
 
HEV-prob JVHEVP (FAM-)TGATTCTCAGCCCTTCGC(-TAMRA) + 5308–5325 
  
        
RYMV RYMV-F2 
 
CTTCAACGGGCTCCAGTG + 3540–3557 80 bp this study 
(RNA virus) RYMV-R2 
 
AGCGGCCAGGTGTTAGAAG - 3619–3601 
  
 
RYMV-prob2 
 
(YYE-)GGATATCTGGGACGGTTCCT(-BHQ1) + 3571–3590 
  
        
HAdV-40 HAdV-F JTVXF GGACGCCTCGGAGTACCTGAG + 18895–18915 96 bp Jothikumar et al 2005 
(DNA virus) HAdV-R JTVXR ACIGTGGGGTTTCTGAACTTGTT - 18990–18968 
  
 
HAdV-prob JTVXP (FAM-)CTGGTGCAGTTCGCCCGTGCCA(-BHQ1) + 18923–18944 
  
        
PAdV PAdV3-F VTB1-PoAdV3f CCTCAACAACCTCATTGATACC + 20574–20595 144 bp Wolf et al 2010 
(DNA virus) PAdV3-R VTB1-PoAdV3r CTTGCAGTAGCGGCCGT - 20718–20702 
  
 
PAdV3-prob VTB1-PoAdV3probe (YYE-)TACGGCCTGCGCTACCGCTCCCA(-BHQ1) + 20668–20690 
  
        
HEV (GI) nestedG1ext-fwd 1661 TTAYGGKGATGCCTTTGATGACACC  + 4329–4353 302 bp Adapted from 
La Rosa et al 2010 (RNA virus) nestedG1ext-rev 1662 TRATAACGGCCATRTTCCAGACAGTATTCC - 4630–4601 
 
 
nestedG1int-fwd 1663 TGTTTGAGAATGACTTTTCTGAGTTTGAYT + 4394–4423 175 bp 
 
  nestedG1int-rev 1664 TTCCAAAACCCTCGCAGYGAC - 4568–4548 
 
  
 
HEV (GIII) nestedG3ext-fwd 1669 GGYGACGCYTATGAGGAGT + 4360–4378 298 bp Adapted from 
La Rosa et al 2010 (RNA virus) nestedG3ext-rev 1670 GCTATRATYGCCATRTTCCA - 4658–4639 
 
  nestedG3int-rev 1672 AGAGACTCCTTCGGSGCYTG - 4580–4561 220 bp   
1 
Genbank accession numbers: NoV-GGII no. X86557; HEV no. AF082843 (sHEV); RYMV  no. L20893; HAdV no. AC_000008 (HAdV5); PAdV no. AB026117 (PAdV3); HEV / GI no. M73218; HEV no. 
AF082843 (sHEV) 
2 
in combination with nestedG3ext-fwd (semi-nested PCR) 
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Table S2 – qPCR assay characteristics 
 
  
2nd target 
(duplex qPCR) efficiency formulae 
Cq threshold 
for LOQ 
LOQ in water 
(GE copies/L) 
Cq threshold 
for LOD 
HEV RYMV 93% Cq = -3.501 × log(conc) + 41.032 35.08 6.50 × 10
4
 42.00 
NoV-GGII RYMV 97% Cq = -3.385 × log(conc) + 39.609 36.25 1.86 × 10
4
 42.00 
HAdV-40 PAdV 102% Cq =-3.272 × log(conc) + 39.748 34.00 9.27 × 10
3
 42.00 
PAdV HAdV-40 97% Cq = -3.394 × log(conc) + 40.180 34.00 5.67 × 10
3
 42.00 
RYMV HEV 99% Cq =-3.350 × log(conc) + 41.886 36.00 9.36 × 10
4
 42.00 
RYMV NoV-GGII 96% Cq = -3.411 × log(conc) + 42.168 36.00 8.70 × 10
4
 42.00 
These LOQ values apply only to samples treated by direct PEG precipitation.   
 
 
 
 
 
Table S3 – Detection of PCR inhibitors by measuring the amplification efficiency of a spiked DNA in WWTP water samples and in distilled water samples 
 
  Quantification cycle (±SD) Calculated concentration (GE.L
-1
) Range (GE.L
-1
) % efficiency 
Influent water extracted sample (n=10) 29.6 ± 0.3 1.88 × 10
3
 1.38 × 10
3
 – 2.55 × 10
3
 81% 
Effluent water extracted sample (n=10) 29.8 ± 0.5 1.65 × 10
3
 6.63 × 10
2
 – 2.22 × 10
3
 71% 
Distilled water sample (n=8) 29.3 ± 0.3 2.31 × 10
3
 1.94 × 10
3
 – 3.09 × 10
3
   
The spiked DNA is a RYMV PCR fragment cloned in pGEM-T. Range is defined by the minimal and the maximal calculated concentrations. 
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Table S4 – Detection of PCR inhibitors by measuring the amplification efficiency of a spiked DNA in WWTP samples and in distilled water samples 
 
  Quantification cycle (±SD) 
Calculated 
concentration (GE.L
-1
) Range  (GE.L
-1
) % efficiency 
Influent water extracted sample + spiked RNA mix (n=4) 26.0 ± 0.2 6.20 × 10
4
 5.93 × 10
4
 – 6.33 × 10
4
 79% 
Elution buffer + spiked RNA mix (n=4) 25.6 ± 0.1 7.87 × 10
4
 7.53 × 10
4
 – 8.16 × 10
4
  
The spiked DNA is a RYMV PCR fragment cloned in pGEM-T. Range is defined by the minimal and the maximal calculated concentrations. 
 
 
 
 
 
 
Figure S1 – Alignment of the sequence of WWTP influent sample G1 with the closest match in NCBI Blast 
 
Hepatitis E virus isolate 5-05-gt1 polymerase (P) gene, partial cds 
Sequence ID: gb|HM641296.1| Length: 326 Number of Matches: 1 
 
Range 1: 152 to 326 
Score Expect Identities Gaps Strand 
307 bits(166)  2e-80  172/175(98%)  0/175(0%)  Plus/Plus 
 
Query  1    TGTTTGAGAATGACTTTTCTGAGTTTGATTCCACCCAGAATAATTTCTCTCTAGGCCTTG  60 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  152  TGTTTGAGAATGACTTTTCTGAGTTTGATTCCACCCAGAATAATTTCTCTCTAGGCCTTG  211 
 
Query  61   AGTGTGCTATTATGGAGGAGTGCGGGATGCCGCAGTGGCTCATCCGTTTGTATCACCTTA  120 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  212  AGTGTGCTATTATGGAGGAGTGCGGGATGCCGCAGTGGCTCATCCGTTTGTATCACCTTA  271 
 
Query  121  TAAGGTCTGCGTGGATCTTGCAGGCCCCGAAGGAGTCACTGCGAGGGTTTTGGAA  175 
            ||||||||||||||||||||||||||||||||||||| ||||| ||||| ||||| 
Sbjct  272  TAAGGTCTGCGTGGATCTTGCAGGCCCCGAAGGAGTCTCTGCGGGGGTTCTGGAA  326 
 
 
